Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

beta-D-glucosylisophosphoramide mustard

Known as: beta-D-Glc-IPM, beta-D-glucosyl-ifosfamide mustard 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Kemiskinan dan budaya konsumtif adalah sesuatu yang sangat bertolak belakang; sebuah paradoks. Kondisi itu terjadi di Indramayu… Expand
2016
2016
New detent-force minimization methodologies for a 6/4 double-sided interior permanent-magnet flat linear brushless motor… Expand
  • figure 2
  • figure 1
  • table I
  • figure 3
  • figure 4
2015
2015
Independent variables such as PAD, DAU, DAK, and SiLPA allegedly not always have linear effect to HDI, due to contingent factors… Expand
Review
2014
Review
2014
BACKGROUND A major component of a systematic review is an assessment of the methodological quality and bias of randomized trials… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2014
2014
We initiate the study of stability of solutions of the 2D inviscid incompressible porous medium equation (IPM). We begin by… Expand
2012
2012
Penelitian ini bertujuan untuk mengetahui pengaruh  realisasi pendapatan asli daerah (PAD), realisasi  dana perimbangan  (dana… Expand
2009
2009
Purposed-19575 (glufosfamide: β-d-glucosylisophosphoramide mustard) is an alkylating agent in which isophosphoramide mustard, the… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2006
2006
This paper presents the practical implementation of a new algorithm for the detection and diagnosis of stator electrical faults… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
1998
1998
A new IGBT-IPM named R-IPM has been developed. This R-IPM consists of only silicon semiconductors chips, so called IPMCMs… Expand
  • figure 2
  • figure 3
  • figure 1
  • table 1
  • figure 4
1996
1996
Abstract β-D-Glucosylisophosphoramide mustard (β-DGlc-IPM) is a new, potential chemotherapeutic agent currently under… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2